Financial Daily from THE HINDU group of publications
Wednesday, Dec 01, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals
Marketing - IPR


Patents Bill likely to be introduced in Parliament amid protests

P.T. Jyothi Datta

Mumbai , Nov. 30

FROM signature campaigns to protest marches and "gheraos on Parliament" to vigils at Indian embassies abroad — The Patents (Third) Amendment Bill is set to elicit all of the above reactions, with the Bill slated to be introduced at the forthcoming winter session of Parliament starting on December 1.

"We apprehend the back-door entry of the product patent regime. Some political parties may play a double game by opposing the Bill on the face of it and refusing to allow it to be tabled in Parliament. This would in turn allow the Government to bring the Bill into force by January 1, 2005 through an ordinance," said Dr Ashwani Mahajan, Member of the national steering committee of the Swadeshi Jagran Manch.

"We are opposed to the Patents Bill as it will make drugs expensive for the masses, by encouraging monopoly by certain companies. This was seen in the case of the cancer drug Glivec, which on getting an exclusive marketing right forced local manufacturers to stop making the same drug at a lesser cost. We will `gherao Parliament' and will keep the protests on," he told Business Line.

Meanwhile, several non-government organisations have also initiated signature campaigns on the Internet, addressed to the Prime Minister and other Ministers, in charge of the relevant departments.

In an e-mail that echoes issues similar to those raised by the domestic pharma industry, Health GAP (Global Access Project), an US advocacy organisation, has urged the Government to bring in the product patent regime in a manner that maximises its flexibilities within the international commitments made by India.

Protest marches are also being organised in Bangalore and Delhi, against bringing in the Patents Bill in its current format, by the Affordable Medicines and Treatment Campaign and the National Working Group on Patent Laws.

More Stories on : Pharmaceuticals | IPR

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
TN annual Plan outlay fixed at Rs 9,100 cr


April - Oct fiscal deficit declines
Refining of edible oil does not attract excise duty: SC
French insurance agency keen to set up shop in India
AIDS vaccine trials in India likely next year
DFID to step up funding for AIDS control schemes
GAIL in talks for stake in China Gas — Plans Rs 2,000 cr investments in Russia
Oil import bill balloons 56 pc
Patents Bill likely to be introduced in Parliament amid protests
Investment decisions — Reliance Energy to consult RIL
CESC in talks to raise funds for Budge Budge project
Transco plans 4 pc tariff cut for HT-I industrial units
States demand 50 per cent share in service tax kitty
Penalty notice for service tax defaulters
KMML plans to set up desalination plant
Future Schools signs pact with US-based society
Visvesvaraya Tech varsity, UGS sign pact
Remove cap on exports, urge rubber merchants
CII-TN to take up profiling of students
Pravasi Bhartiya Divas to be held in Mumbai from Jan 7
Architectural expo in Kottayam
NGRI seminar from tomorrow
IIT alumni to hold meet in Delhi
In Hyderabad today
Kamal Nath to meet export promotion councils on Dec 11



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line